Skip to content

What Hims and Hers GLP-1 programs cost in 2026

Updated Sep 30, 2026. Numbers in brackets link to the source each fact comes from.

A Hims or Hers GLP-1 plan costs two things: a weight-loss membership of $39 for the first month and $149 a month after that, plus the medication, which starts at $149 a month in cash [1] [2]. At the lowest advertised prices, that adds up to $188 for the first month and $298 a month after that [1] [2].

Hims and Hers are two brands of one company, Hims & Hers Health, and they run the same weight-loss program; the company’s announcements point readers to both brands’ weight-loss pages [4].

The two parts of the bill

The membership and the medication are billed separately, and you cannot get the medication without the membership [1] [3].

Charge Price What it covers
Membership, first month $39 [1] Care team, check-ins, nutrition guidance
Membership, each month after $149 [1] Same; renews automatically
Brand-name medication From $149 a month [2] The medicine only [3]

The membership includes round-the-clock access to providers, personalized nutrition guidance, clinical check-ins and a peer community [5]. The company says splitting the medication from care fees lets members seek HSA or FSA reimbursement [6], though eligibility depends on your plan [7]. A prescription is not guaranteed: the company says the membership fee does not include or guarantee one [1].

What they prescribe, and the drug prices

Since March 2026 the program offers Wegovy pills, Wegovy injections and Ozempic injections [8]. Ozempic is not FDA-approved for weight loss, which the company itself notes; providers may prescribe it off-label [9]. Its providers can also send Zepbound vial and KwikPen prescriptions, and Foundayo prescriptions, to Lilly’s LillyDirect pharmacy, where customers pay LillyDirect’s self-pay prices [10].

That makes the Lilly drug prices easy to check. LillyDirect lists Zepbound from $299 a month at the starting dose [11], rising to $449 a month at the top dose when refilled within 45 days [12]. Foundayo starts at $149 a month [13]. For Wegovy and Ozempic, Novo Nordisk says the company charges the same self-pay prices as other telehealth platforms [14]. In other words, for these drugs the medication price is meant to match what you would pay elsewhere; the membership is the extra.

The GLP-1 list on the Hims weight-loss page, which we read in a browser on September 29, 2026 because the page blocks automated reading, gives these monthly medication prices: the Wegovy pill from $149 [23], the Wegovy pen from $199 [24], Zepbound vials from $299 [25] and KwikPens from $299 [26], the Foundayo pill from $149 [27], the Ozempic pill from $149 [28], Ozempic from $199 [29], and Mounjaro [30] and Zepbound [31] at $1,899. It also lists a “Wegovy Pill Microdosing Plan” from $149 a month [32]. These prices cover the medication only [33]; the membership is on top.

What about compounded semaglutide?

Until 2026, Hims and Hers sold compounded semaglutide, which is what FDA’s 2025 warning letters were about [17]. In March 2026 Novo Nordisk announced that Hims & Hers would stop advertising compounded GLP-1s and would let existing patients move to FDA-approved drugs [15]. The company’s own March 2026 announcement still describes its semaglutide offerings as “branded and compounded” [16], so compounded drugs are not advertised but may not have disappeared entirely.

The FDA warning letters and their status

In August 2025 FDA reviewed the Hims and Hers websites and found both offering compounded drugs, including semaglutide [17] [18]. It sent a warning letter to each brand dated September 9, 2025 [19]. FDA said the claims implied the compounded products were the same as an FDA-approved product when they are not [20]. In February 2026 FDA again named Hims & Hers among companies mass-marketing non-approved compounded GLP-1s as alternatives to approved drugs [21].

FDA issues a close-out letter only after it has checked a company’s corrective actions [22]. When we checked FDA’s warning letter database for this page, no close-out letter was listed for either letter, so we treat them as unresolved. That is why we name Hims and Hers but do not link to them. Our Hims & Hers review covers the record in more detail.

Is it worth the membership?

If you value a care team, check-ins and one app for your prescription, the membership buys that. If you only want the medicine at the lowest price, compare the makers’ own self-pay prices and other programs in our brand-name GLP-1 cash price guide before you join. Before signing up anywhere, find the cancellation terms at checkout; our guide to cancelling a GLP-1 program lists what to look for.

Sources

  1. Price includes membership fee only ($39 for the first month, auto-renews at $149/month thereafter). Billed separately and does not include or guarantee a prescription. Medication is not available without a membership. news.hims.com, read Sep 27, 2026.
  2. With cash-pay prices starting at $149 a month news.hims.com, read Sep 27, 2026.
  3. Price includes medication only, if prescribed. An active Him & Hers Weight Loss Membership is required and fee not included ($39 for the first month, auto-renews at $149/month thereafter). news.hims.com, read Sep 27, 2026.
  4. For more information, visit www.hims.com/weight-loss or www.forhers.com/weight-loss news.hims.com, read Sep 27, 2026.
  5. Now alongside comprehensive support services, 24/7 direct access to providers, personalized nutrition guidance, ongoing clinical check-ins, members can also access peer support in the Hims & Hers Weight Loss community. news.hims.com, read Sep 27, 2026.
  6. Separating medication costs from care fees allows for HSA or FSA reimbursement news.hims.com, read Sep 27, 2026.
  7. FSA & HSA eligibility and coverage vary by plan provider. news.hims.com, read Sep 27, 2026.
  8. Hims & Hers is offering direct access to Wegovy® pills, Wegovy injections and Ozempic® injections news.hims.com, read Sep 27, 2026.
  9. Ozempic is not FDA-approved for weight loss. Providers may, in their clinical discretion, prescribe it off-label if deemed appropriate for their patient. news.hims.com, read Sep 27, 2026.
  10. Now, providers on our platform can send prescriptions for Zepbound® vials and KwikPen®, as well as Foundayo™, to the LillyDirect® pharmacy and access self-pay pricing for Hims & Hers customers news.hims.com, read Sep 27, 2026.
  11. 2.5 mg/0.5 mL (starting dosage) Self-pay price: Starting at $299/month* lilly.com, read Sep 27, 2026.
  12. 15 mg/0.5 mL Self-pay price: Starting at $449/month* when you refill within 45 days lilly.com, read Sep 27, 2026.
  13. 0.8 mg dose (starting dosage) Self-pay price: Starting at $149/month lilly.com, read Sep 27, 2026.
  14. to US consumers at the same affordable self-pay prices as other telehealth platforms. novonordisk.com, read Sep 27, 2026.
  15. Hims & Hers will no longer advertise compounded GLP-1 offerings on its platform or in its marketing, and existing patients will have the opportunity to transition to FDA-approved alternatives when clinically appropriate in consultation with a healthcare professional. novonordisk.com, read Sep 27, 2026.
  16. updating access to the semaglutide offerings available on our platform (branded and compounded) news.hims.com, read Sep 27, 2026.
  17. This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website content at the internet address https://www.hims.com in August 2025 and has observed that your website offers various compounded drug products, including semaglutide. fda.gov, read Sep 27, 2026.
  18. This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website content at the internet address https://www.forhers.com in August 2025 and has observed that your website offers various compounded drug products, including semaglutide. fda.gov, read Sep 27, 2026.
  19. WARNING LETTER September 9, 2025 fda.gov, read Sep 27, 2026.
  20. Your claims imply that your products are the same as an FDA-approved product when they are not. fda.gov, read Sep 27, 2026.
  21. intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies — including Hims & Hers and other compounding pharmacies — as similar alternatives to FDA-approved drugs. fda.gov, read Sep 27, 2026.
  22. FDA may issue a Warning Letter close-out letter (“close-out letter”) once the Agency has completed an evaluation of corrective actions undertaken by a firm in response to a Warning Letter. fda.gov, read Sep 27, 2026.
  23. Wegovy® Pill From $149/mo† hims.com, read Sep 29, 2026.
  24. Wegovy® Pen From $199/mo† hims.com, read Sep 29, 2026.
  25. Zepbound® Vial From $299/mo† hims.com, read Sep 29, 2026.
  26. Zepbound® KwikPen® From $299/mo† hims.com, read Sep 29, 2026.
  27. Foundayo™ Pill From $149/mo† hims.com, read Sep 29, 2026.
  28. Ozempic® Pill From $149/mo† hims.com, read Sep 29, 2026.
  29. Ozempic® From $199/mo† hims.com, read Sep 29, 2026.
  30. Mounjaro® $1,899/mo† hims.com, read Sep 29, 2026.
  31. Zepbound® $1,899/mo† hims.com, read Sep 29, 2026.
  32. Wegovy® Pill Microdosing Plan From $149/mo† hims.com, read Sep 29, 2026.
  33. Price includes medication only, if prescribed. hims.com, read Sep 29, 2026.